UPC_APP_68359/2024

TRANSCUTANEOUS ANALYTE SENSORS, APPLICATORS THEREFOR, AND NEEDLE HUB COMPRISING ANTI-ROTATION FEATURE

Prozessuale & UnteranträgeRücknahmeanträgeMunich LDApplication Rop 265—Vergleich erfolgt: Vor Hauptsache

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Dexcom Inc.(Dexcom Group)

Vertreter: Marcus Grosch (Quinn Emanuel)

Beklagte

Abbott Laboratories(Abbott Group)
Abbott Diabetes Care Inc.(Abbott Group)
Abbott GmbH(Abbott Group)
Abbott Diagnostics GmbH(Abbott Group)
Abbott Laboratories GmbH(Abbott Group)
Abbott Logistics B.V.(Abbott Group)
Abbott France (S.A.S.)(Abbott Group)
Abbott s.r.l.(Abbott Group)
Abbott Gesellschaft m.b.H.(Abbott Group)
Abbott B.V.(Abbott Group)
Abbott (S.A./N.V.)(Abbott Group)
Abbott Scandinavia Aktiebolag(Abbott Group)
Abbott Oy(Abbott Group)

Vertreter: Dietrich Burkhard Kamlah (Taylor Wessing)

Richter

Ulrike VoßPresiding judge and judge-rapporteur
Daniel VoßLegally qualified judge
Petri RinkinenLegally qualified judge
Claus ElmerosTechnically qualified judge

Patente

EP 4 111 949

CPC-Codes: A61B5/6849, A61B2560/063, A61B5/0004, A61B5/14532, A61B5/14546, A61B5/1473, A61B5/6848, A61B5/6833, A61B5/14503

Sektor: Pharmaceutical & Medical

Ausgang

Zurückgenommen

Eingereicht: —

Erste Entscheidung: 10. Jan. 2025

Sprache: —

Vergleich erfolgt: Vor Hauptsache — settled commercially

Decision of the Munich Local Division permitting withdrawal of the infringement action by Dexcom Inc. against Abbott Laboratories and multiple Abbott entities, and withdrawal of the counterclaim for revocation and patent amendment application by the defendants. All parties mutually consented to withdrawal prior to the final decision date. Each party bears its own costs.